Pan-cancer genome analysis of The Cancer Genome Atlas (TCGA) revealed that NRF2 activation was particularly enhanced in non-small cell lung cancer (NSCLC)5. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.